Neurostimulation Devices Market Analysis Report | Size & Share 2030
[研究报告] 神经刺激设备市场预计将从 2022 年的 58.0247 亿美元增长,到 2030 年有望达到 118.2595 亿美元;预计 2022 年至 2030 年的复合年增长率为 9.3%。
市场洞察和分析师观点:
神经刺激装置是用于调节神经系统活动的医疗设备。它们用于治疗各种神经系统疾病和慢性疼痛。神经刺激装置有多种类型,包括脊髓刺激器、深部脑刺激器、迷走神经刺激器和外周神经刺激器。这些装置可以显著改善患有各种神经系统疾病的人的生活质量。神经系统疾病的患病率不断上升和脊髓损伤病例的增加是市场发展的关键因素。然而,缺乏专业人才阻碍了神经 刺激装置市场的增长。
增长动力和挑战:
老年人群易患神经系统疾病。影响老年人的常见神经系统疾病包括神经病、帕金森病、阿尔茨海默病、肌张力障碍等。根据美国国立卫生研究院 (NIH) 的数据,世界人口的 8.5%(即约 6.17 亿人)年龄在 65 岁及以上。美国和加拿大等国家老年人口不断增长,运动障碍和精神疾病的患病率也很高。根据帕金森基金会的数据,帕金森症状在平均 60 岁时很常见。
加拿大心理协会表示,强迫症 (OCD) 影响着加拿大约 2% 的人口。世界卫生组织 (WHO) 表示,癫痫是一种引起癫痫发作的神经系统疾病,影响着全球约 5000 万人。根据美国神经病学学会的数据,中风是美国第三大死亡原因,其次是阿尔茨海默氏症,后者是第六大死亡原因。同一来源的统计数据显示,近一百万美国人患有帕金森氏症,每年至少有 60,000 例新病例报告。神经系统疾病发病率的不断上升,加上抑郁症和慢性疼痛等生活方式相关疾病,导致人们越来越多地采用技术先进的产品。
根据世界卫生组织的数据,神经疾病占全球疾病负担的约 6.3%。此外,根据同一来源的数据,神经疾病是全球死亡的主要原因之一。它们导致发达国家 13.2% 的死亡,导致中低收入国家 16.8% 的死亡。高死亡率和疾病负担使得临床迫切需要整合长期解决方案。此外,人们越来越意识到神经系统疾病的巨大负担,这也增加了对神经刺激器作为治疗方法的需求。
因此,老年人口的不断增长、神经系统疾病的患病率的不断上升以及对神经系统疾病巨大负担的认识的不断提高推动了神经刺激设备的市场规模。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
神经刺激设备市场:
Neurostimulation Devices Market: Strategic Insights
Neurostimulation Devices Market
-
CAGR (2022 - 2030)
9.3%
-
Market Size 2022
US$ 5.8 Billion
-
Market Size 2030
US$ 11.83 Billion
Market Dynamics
GROWTH DRIVERS
- XXXXXXX
- XXXXXXX
- XXXXXXX
FUTURE TRENDS
- XXXXXXX
- XXXXXXX
- XXXXXXX
OPPORTUNITIES
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Medtronic Plc
- Boston Scientific Corp
- Abbott Laboratories
- Nevro Corp
- LivaNova Plc
- Synapse Biomedical Inc
- Nalu Medical Inc
- ElectroCore Inc
- MicroTransponder Inc
Regional Overview
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
产品(脊髓刺激器、深部脑刺激器、骶神经刺激器、迷走神经刺激器等)
应用(疼痛管理、癫痫、尿失禁和大便失禁、帕金森病等)
最终用户(医院、专科诊所等)
地理(北美洲、欧洲、亚太地区、中东和非洲、南美洲和中美洲)
Neurostimulation Devices Market: Strategic Insights
-
CAGR (2022 - 2030)9.3% -
Market Size 2022
US$ 5.8 Billion -
Market Size 2030
US$ 11.83 Billion
Market Dynamics
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Medtronic Plc
- Boston Scientific Corp
- Abbott Laboratories
- Nevro Corp
- LivaNova Plc
- Synapse Biomedical Inc
- Nalu Medical Inc
- ElectroCore Inc
- MicroTransponder Inc
Regional Overview
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
复合年增长率(2022 - 2030 年)9.3%- 2022 年市场规模
58 亿美元 - 2030 年市场规模
118.3 亿美元
市场动态
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
关键人物;主力;重要一员
- 美敦力公司
- 波士顿科学公司
- 雅培实验室
- 内夫罗公司
- 利瓦诺瓦股份有限公司
- Synapse生物医学公司
- Nalu 医疗公司
- 电芯公司
- 微型转发器公司
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 脊髓刺激器
- 深部脑刺激器
- 骶神经刺激器
- 迷走神经刺激器
- 其他的
- 疼痛管理
- 癫痫
- 尿失禁和大便失禁
- 帕金森病
- 其他的
- 医院
- 专科诊所
- 其他的
- 北美
- 欧洲
- 亚太地区
- 中东和非洲
- 南美洲和中美洲
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
报告细分和范围:
全球神经刺激设备市场根据产品、应用和最终用户进行细分。根据产品,市场细分为脊髓刺激器、深部脑刺激器、骶神经刺激器和迷走神经刺激器。根据应用,神经刺激设备市场细分为疼痛管理、癫痫、尿失禁和大便失禁、帕金森病等。根据最终用户,神经刺激设备市场细分为医院、专科诊所等。根据地理区域,神经刺激设备市场分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、俄罗斯和欧洲其他地区)、亚太地区(澳大利亚、中国、日本、印度、韩国和亚太其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。
节段分析:
根据产品,神经刺激设备市场细分为脊髓刺激器、深部脑刺激器、骶神经刺激器、迷走神经刺激器等。脊髓刺激器细分市场在 2022 年占据最大市场份额,预计在 2022-2030 年期间的复合年增长率将更高。脊髓刺激可以治疗因各种情况而导致严重慢性疼痛的患者,包括背部手术失败/蛛网膜炎、神经性疼痛/神经病变以及复杂的局部疼痛综合征/反射性交感神经营养不良。一些 SCS 设备使用低频电流来改变疼痛感,并产生轻微的刺痛感(称为感觉异常)。其他 SCS 设备使用高频或突发脉冲来掩盖疼痛,而不会产生刺痛感。
脊髓刺激已成为治疗各种慢性疼痛疾病的介入性疼痛管理的基础。自 1967 年首次问世以来,脊髓刺激取得了进展,催生了允许微创放置和内置电池的新技术。例如,2023 年 5 月,雅培获得美国食品药品监督管理局 (FDA) 批准,用于治疗无法接受背部手术的人群的慢性背痛(称为非手术背痛)。此外,2023 年 8 月,美敦力公司获得了其 Inceptiv 闭环可充电 SCS 的 CE 标志批准。这是第一款提供闭环功能的美敦力 SCS 设备,该功能可感知每个人独特的生物信号并根据需要随时调整刺激,以使治疗与日常生活动作保持一致。这些发展正在推动 SCS 的采用,推动全球神经刺激设备市场细分市场的增长。
根据应用,神经刺激设备市场分为疼痛管理、癫痫、尿失禁和大便失禁、帕金森病等。疼痛管理领域在 2022 年占据了最大的市场份额,预计在 2022-2030 年期间将实现更高的复合年增长率。
慢性疼痛会影响老年人、创伤和手术患者、接受不同治疗的人以及与各种身体和精神疾病相关的人。根据美国疾病控制和预防中心 (CDC) 的数据,背痛是就诊的第二大原因,约 60% 和 80% 的人在一生中都会经历下背痛,这是入院或手术的主要原因之一。
神经刺激是一种更安全、更有效的缓解慢性疼痛的方法,已被广泛采用。许多生物技术公司正在推出神经刺激器,帮助阿片类药物成瘾者克服疼痛和其他戒断症状。例如,2021 年 4 月,领先的医疗器械公司 Spark Biomedical 推出了一种名为 Sparrow Therapy System 的新型神经刺激装置,帮助阿片类药物成瘾者克服戒断症状。该装置使用低剂量的电刺激内啡肽的产生,有助于缓解患者在戒断期间所经历的疼痛和恐惧。此外,2021 年 3 月,Mainstay Medical 在澳大利亚推出了一种用于治疗慢性腰痛 (CLBP) 的植入式神经刺激装置 ReActiv8。该装置可能对患有与腰椎多裂肌功能障碍相关的难治性 CLBP 的成年人有帮助。2023 年 1 月,FDA 批准了雅培的 Proclaim XR 脊髓神经刺激系统,该系统支持糖尿病周围神经病变患者控制慢性疼痛。因此,上述应用和好处将对 2022-2030 年期间的神经刺激设备市场产生积极影响。
区域分析:
根据地理位置,神经刺激设备市场分为五个主要区域:北美、欧洲、亚太地区、南美和中美以及中东和非洲。北美市场分析主要关注三个主要国家——美国、加拿大和墨西哥。2022 年,美国占据北美神经刺激设备市场的最大份额。由于神经系统疾病的患病率不断上升、研发支出高、美国食品药品监督管理局 (FDA) 的产品批准以及技术进步,预计在预测期内,美国将占据北美神经刺激设备市场的最大份额。在美国,神经血管疾病的发病率正在显著上升,并正在成为死亡的主要原因。帕金森病 (PD) 等神经系统疾病发病率的上升、人们对神经系统疾病的认识不断提高以及对开发颅内刺激器的投资不断增加是推动美国整体神经刺激设备市场发展的主要因素。据观察,深部脑刺激 (DBS)设备可以有效控制与帕金森病相关的震颤。多巴胺读数低和其他遗传因素是导致帕金森病的主要原因之一。根据阿尔茨海默病协会发表的一项题为“2022 年阿尔茨海默病事实和数据”的研究,2022 年,近 650 万 65 岁及以上的美国人被诊断出患有阿尔茨海默病。预计到 2060 年,这一数字将上升到 1380 万。根据帕金森基金会的数据,到 2030 年,美国患帕金森病的人数预计将增加到 120 万。技术进步和新产品的推出推动了神经刺激设备市场的发展。2020 年 1 月,雅培的神经刺激器 Infinity DBS 系统获得了美国食品药品监督管理局的批准,用于治疗帕金森病。该系统可以针对大脑的特定区域进行有针对性的治疗,该区域称为内苍白球 (GPi),与帕金森病的症状有关。因此,神经系统疾病的日益流行和技术进步推动了美国神经刺激设备市场的增长。
竞争格局和重点公司:
神经刺激设备市场的发展被描述为有机和无机增长战略。各公司专注于有机增长战略,如产品发布、扩张、增强和迁移。市场中的无机增长战略包括并购、伙伴关系和合作。这些活动为神经刺激设备市场参与者的业务和客户群的扩张铺平了道路。
- 2023 年 8 月,Mainstay Medical Holdings plc 宣布其 RESTORE 随机临床研究 ReActiv8 已完成招募,该研究旨在治疗难治性慢性腰痛。该研究旨在与优化的医疗管理进行直接比较,以检验以下假设:将 ReActiv8 修复性神经刺激疗法添加到当前护理模式中可显著改善背痛相关的残疾。
- 2023 年 4 月,Synapse Biomedical, Inc. 宣布 NeuRx 膈肌起搏系统 (NeuRx DPS) 获得 FDA 批准 (PMA),用于依赖机械通气的脊髓损伤患者。PMA 是 FDA 要求的最严格的设备营销申请类型。
- 2023 年 8 月,雅培宣布美国食品药品监督管理局 (FDA) 批准了其采用 FlexBurst360 疗法的新型 Proclaim Plus 脊髓刺激 (SCS) 系统。雅培专有的 BurstDR 刺激的下一代产品 FlexBurst360 疗法可覆盖躯干和/或四肢的六个部位的疼痛。它可以根据患者的治疗需求变化进行编程调整。
- 2023 年 5 月,雅培宣布美国食品药品监督管理局 (FDA) 批准其脊髓刺激(SCS) 设备用于治疗未接受或没有资格接受背部手术的人群的慢性背痛,即非手术性背痛。
- 2021 年 1 月,美敦力公司获得美国食品药品监督管理局 (FDA) 批准,生产高性能免充电植入式神经刺激器 (INS) Vanta,其设备寿命可优化至 11 年。在同等设置下,Vanta 神经刺激器的使用寿命几乎是竞争对手原电池设备的两倍。
- 2022年1月,美敦力公司获得美国食品药品监督管理局的批准,其Intellis可充电神经刺激器和Vanta免充电神经刺激器可用于治疗与糖尿病周围神经病变(DPN)相关的慢性疼痛。
神经刺激设备市场报告范围
报告属性 | 细节 |
---|---|
2022 年市场规模 | 58亿美元 |
2030 年的市场规模 | 118.3亿美元 |
全球复合年增长率(2022 - 2030 年) | 9.3% |
历史数据 | 2020-2021 |
预测期 | 2023-2030 |
涵盖的领域 | 按产品
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
公司简介
- 美敦力公司
- 波士顿科学公司
- 雅培实验室
- 内夫罗公司
- 利瓦诺瓦股份有限公司
- Synapse生物医学公司
- Nalu 医疗公司
- 电芯公司
- 微型转发器公司
- 主力医疗
Neurostimulation Devices Market Report Scope
Report Attribute | Details |
---|---|
Market size in | US$ 5.8 Billion |
Market Size by | US$ 11.83 Billion |
Global CAGR | 9.3% |
Historical Data | 2020-2021 |
Forecast period | 2023-2030 |
Segments Covered |
By 产品(脊髓刺激器、深部脑刺激器、骶神经刺激器、迷走神经刺激器等) |
Regions and Countries Covered |
北美(美国、加拿大、墨西哥)
|
Market leaders and key company profiles |
|
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The factors that are driving the market is the growing prevalence of neurological diseases and increasing cases of spinal cord injury are the key driving factors behind the market development. However, lack of expert professionals is hampering the market growth.
The neurostimulation devices market majorly consists of the players such Medtronic Plc, Boston Scientific Corp; Abbott Laboratories, Nevro Corp; LivaNova Plc, Synapse Biomedical Inc, Nalu Medical, Inc, ElectroCore Inc; MicroTransponder Inc, and Mainstay Medical among others.
The neurostimulation devices market is analyzed in the product, application, and end user. The market based on product, is segmented into spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and others. The spinal cord stimulator segment held a larger market share in 2022 and the same is anticipated to register a higher CAGR during the 2022-2030. The neurostimulation devices market, by application, is segmented into pain management, epilepsy, urinary and fecal incontinence, Parkinson’s disease, and others. The pain management segment held a larger market share in 2022 and the same is anticipated to register a higher CAGR during the 2022-2030. The neurostimulation devices market, by end user, is bifurcated into hospitals, specialty clinics, and others. The hospitals segment held the largest share of the market in 2022 and specialty clinics segment is anticipated to register the highest CAGR in the market during 2022-2030.
Neurostimulation devices are medical devices designed to modulate the activity of the nervous system. They are used to treat various neurological conditions and chronic pain. There are several types of neurostimulation devices, including spinal cord stimulators, deep brain stimulators, vagus nerve stimulators, peripheral nerve stimulator. These devices have the potential to significantly improve the quality of life for individuals with various neurological conditions.
The List of Companies - Neurostimulation Devices Market
- Medtronic Plc
- Boston Scientific Corp
- Abbott Laboratories
- Nevro Corp
- LivaNova Plc
- Synapse Biomedical Inc
- Nalu Medical, Inc
- ElectroCore Inc
- MicroTransponder Inc
- Mainstay Medical
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.